美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

KraneShares MSCI All China Health Care Index ETF

17.97

-0.3400-1.86%

盤後：17.970.00000.00%19:30 EDT

成交量：3.26萬

成交額：58.74萬

市值：1.06億

市盈率：- -

高：18.30

開：18.21

低：17.94

收：18.31

52周最高：21.50

52周最低：14.38

股本：590.02萬

流通股本：590.02萬

量比：0.65

換手率：0.55%

股息：0.71

股息率：3.98%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

石藥集團(01093)：SYS 6010於中國獲國家藥監局納入突破性治療品種名單用於治療驅動基因陰性非鱗狀非小細胞肺癌患者

可以多活8.2個月！國產雙抗挑戰全球腫瘤「藥王」總生存期勝出

智通港股早知道 | 國產創新藥WCLC數據密集兑現投行看好中國CRO/CDMO復甦明確

智通港股解盤 | 美國放緩AI另有玄機 WCLC大會再度催化創新藥

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/KURE"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":17.97,"timestamp":1789502400000,"preClose":18.31,"halted":0,"volume":32555,"hourTrading":{"tag":"盘后","latestPrice":17.97,"preClose":17.97,"latestTime":"19:30 EDT","volume":9,"amount":161.87,"timestamp":1789515005859,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.018569087930092838,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"已收盤","change":-0.34,"latestTime":"09-15 16:00:00 EDT","open":18.21,"high":18.3,"low":17.94,"amount":587420.01093,"amplitude":0.019661,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.31,"sharesOutstanding":4750002,"nav":18.27,"aum":107783690.07,"dividendRate":0.039777,"bidAskSpread":0.009753,"preHourTrading":{"tag":"盘前","latestPrice":18.63,"preClose":18.31,"latestTime":"07:23 EDT","volume":15,"amount":279.45,"timestamp":1789471410662,"change":0.32,"changeRate":0.017477,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":17.97,"preClose":17.97,"latestTime":"19:30 EDT","volume":9,"amount":161.87,"timestamp":1789515005859,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6523,"impliedVol":0.2555,"impliedVolPercentile":0.51},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6523,"shares":5900168,"dividePrice":0.7148,"high":18.3,"amplitude":0.019661,"preClose":18.31,"low":17.94,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":17.97,"eps":0,"divideRate":0.039777,"volume":32555,"delay":0,"ttmEps":0,"open":18.21,"prevYearClose":17.04,"prevWeekClose":17.74,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":18.72,"twentyDayClose":18.6,"sixtyDayClose":14.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667645058","title":"石藥集團(01093)：SYS 6010於中國獲國家藥監局納入突破性治療品種名單用於治療驅動基因陰性非鱗狀非小細胞肺癌患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645058","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645058?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 18:04","pubTimestamp":1789466653,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的SYS 6010近日获中华人民共和国国家药品监督管理局纳入突破性治疗品种名单，拟定适应症为既往接受过免疫治疗及含铂化疗治疗失败的复发或转移性驱动基因阴性非鳞状非小细胞肺癌。目前，评估该产品单药用于经标准治疗失败的驱动基因阴性局部晚期或转移性非鳞状非小细胞肺癌的随机、开放、多中心III期临床试验正在开展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"石药集团(01093)：SYS 6010于中国获国家药监局纳入突破性治疗品种名单用于治疗驱动基因阴性非鳞状非小细胞肺癌患者","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","IE00B543WZ88.USD","LU0880133367.SGD","LU0067412154.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","BK1191","LU1813983027.USD","LU0315179316.USD","BK1521","LU1152091754.HKD","IE00B031HY20.USD","LU1226287529.USD","01093","SG9999004220.SGD","LU1008478684.HKD","IE00BZ08YR35.GBP","BK1515","LU1226287875.USD","LU1993786604.SGD","LU0501845795.SGD","LU0072913022.USD","LU1226287792.SGD","LU0314109678.HKD","LU1328277881.USD","LU1951186391.HKD","LU1226288253.USD","IE00B5MMRT66.SGD","LU1152091168.USD","LU0326950275.SGD","IE0008369823.USD","LU0140636845.USD","IE00BZ08YT58.USD","LU1226288170.HKD","KURE","LU1807302812.USD","LU1960683339.HKD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667648612","title":"可以多活8.2個月！國產雙抗挑戰全球腫瘤「藥王」總生存期勝出","url":"https://stock-news.laohu8.com/highlight/detail?id=2667648612","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667648612?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:46","pubTimestamp":1789461960,"startTime":"0","endTime":"0","summary":"2026年世界肺癌大会，对于国产创新药而言，不只是“被看见”，更要回答一个硬核的问题：到底能不能让患者活得更久。继翰森制药ADC药物刷新全球小细胞肺癌二线治疗最长总生存期（OS）纪录外，另外一款国产创新药挑战全球肿瘤“药王”总生存期的数据也揭晓了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609153874734252.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609153874734252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2461242641.AUD","LU1934455863.HKD","LU1989772923.USD","KURE","LU2023250843.SGD","IE00B4R5TH58.HKD","LU2476274720.SGD","LU0823416689.USD","LU1961090484.USD","SG9999002232.USD","09926","LU0477156953.USD","LU0348783233.USD","SG9999001176.SGD","LU0965508806.USD","LU0348825331.USD","LU2361044865.SGD","LU2399975544.HKD","LU2360032135.SGD","SG9999002224.SGD","BK4533","IE00BBT3K403.USD","LU0289739343.SGD","LU1989771016.USD","LU0208291251.USD","LU1941712348.USD","FHLC","LU0070302665.USD","LU0634319403.HKD","SG9999001440.SGD","LU1032466523.USD","MRK","GDOC","XLV","LU0348735423.USD","VHT","IE00BFTCPJ56.SGD","LU2488822045.USD","LU2778985437.USD","LU1116320901.HKD","IE00BLSP4452.SGD","BK4559","LU0098860793.USD","LU0122379950.USD","LU1023059063.AUD","PPH","LU1116320737.USD","LU0472753341.HKD","LU1066051225.USD","IE00B543WZ88.USD","LU0980610538.SGD","LU0130517989.USD","IE00BLSP4239.USD","LU1093756168.USD","LU1035773651.USD","LU2125154778.USD","LU2125909247.SGD","LU0417516902.SGD","LU0511384066.AUD","LU1162221912.USD","IE00B2B36J28.USD","LU1934455277.USD","LU0861579265.USD","RXL","BK4550","LU0203347892.USD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU0124676726.USD","LU1571399168.USD","BMED","BK4585","LU1061106388.HKD","LU1989772840.SGD","IE00BSNM7G36.USD","LU1720050803.USD","IE00BPRC5H50.USD","LU0130102774.USD","LU0238689110.USD","LU1093756325.SGD","LU0868494617.USD","LU0868494708.USD","LU2125154935.USD","LU0289961442.SGD","LU0942090050.USD","SG9999001176.USD","LU0265550359.USD","PAWZ","IHE","IE0002141913.USD","LU0006306889.USD","LU0689626769.HKD","LU1923622614.USD","BK4516","LU0069063385.USD","LU0648001328.SGD","LU2361045086.USD","LU1585245621.USD","LU0965509010.AUD","LU1066051498.USD","LU0965509101.SGD","HRTS","LU0320765489.SGD","LU1941712264.USD","LU0348784397.USD","LU2023250504.SGD","LU0266013472.USD","LU1929549753.HKD","SG9999014559.SGD","LU2491050154.USD","LU0348767384.USD","BK4007","LU0106261372.USD","LU0417516738.SGD","LU0234572021.USD","LU0561508036.HKD","LU2491050071.SGD","SG9999014567.USD","LU1037948897.HKD","IXJ","LU0057025933.USD","LU1794554557.SGD","LU1983299246.USD","LU2361044949.HKD","LU0348766576.USD","IE000M9KFDE8.USD","LU2089984988.USD","LU1974910355.USD","LU0348827113.USD","LU2125909593.SGD","TRUH","JDOC","LU1066051811.HKD","LU2357627491.SGD","LU0320765646.SGD","SG9999015358.SGD","LU2491049909.HKD","LU1430594728.SGD","LU1201861249.SGD","IE00B1BXHZ80.USD","LU0211331839.USD","LU1291159041.SGD","LU2433249047.HKD","LU1917777945.USD","FTXH","LU0965509283.SGD","LU2468319806.SGD","LU2112291526.USD","LU0265550946.USD","IE00BJT1NW94.SGD","LU2324357040.USD","BK1574","LU1037948541.HKD","LU2106854487.HKD","BK1161","IE0009355771.USD","LU0985320562.USD","LU1057294990.SGD","LU0058720904.USD","LU1934455194.USD","SGXZ57979304.SGD","IYH","LU0289739699.SGD","LU0417516571.SGD","LU0203345920.USD","BK4534","LU2476274308.USD","LU0859254822.USD","LU1699723380.USD","BK4588","SG9999014575.USD","SG9999013999.USD","IE00B5MMRT66.SGD","SG9999015341.SGD","SG9999014542.SGD","LU1069347547.HKD","LU0540923850.HKD","IE00BN8TJ469.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691412","title":"智通港股早知道 | 國產創新藥WCLC數據密集兑現 投行看好中國CRO/CDMO復甦明確","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691412","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691412?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 07:29","pubTimestamp":1789428595,"startTime":"0","endTime":"0","summary":"WCLC临床数据密集兑现，国内外投行相继看好中国CRO/CDMO复苏明确9月12日至15日，2026年世界肺癌大会在韩国首尔举行，多项国产创新药临床数据集中亮相，中国新药入选口头报告19项、小型口头报告45项，双双刷新历史纪录，肺癌领域ADC与双抗数据成为焦点。经初步测算，本次交易完成后，一汽股份将成为公司第二大和具有战略影响力的股东;本次交易预计构成重大资产重组及关联交易，不构成公司实际控制人变更，不构成重组上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008369823.USD","IE0008368742.USD","06871","LU1226287875.USD","BK1574","BK1183","LU1328277881.USD","CDMO","BK4139","BK1539","LU2039709279.SGD","IBBQ","01911","LU1960683339.HKD","06978","LU1951186391.HKD","02238","LU0501845795.SGD","BK1147","IE00B543WZ88.USD","LU1226287792.SGD","SG9999004220.SGD","159992","LU0315179316.USD","VXUS","BK1144","IE00BZ08YT58.USD","LU1813983027.USD","BK1161","02889","BK1119","BK4588","LU1226288170.HKD","LNGR","KCAI","LU1008478684.HKD","LU0140636845.USD","LU0326950275.SGD","HK0000165453.HKD","LU1152091754.HKD","LU1226287529.USD","MEDX","LU0314109678.HKD","01093","KURE","BK1191","LU1993786604.SGD","BK4585","BK1521","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666143","title":"智通港股解盤 | 美國放緩AI另有玄機 WCLC大會再度催化創新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666143?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 20:45","pubTimestamp":1789389921,"startTime":"0","endTime":"0","summary":"科技股的走弱，和 Anthropic、OpenAI 与 SpaceX 罕见联手集体呼吁放缓AI 开发步伐有关。业绩方面，多光谱 AI 大模型服务收入冲到 3.20 亿元，同比暴涨 382.5%，收入占比直接从 29.8% 飙升至 78%。机构认为，2026 年 WCLC 大会的主角仍是 IO2.0 与 ADC，肺癌领域尤其是 1L 非小细胞肺癌的标准治疗范式正处于迭代前夜，国产双抗与 ADC 的进度全球领先。授权品种的里程碑付款与商业化分成，正在成为创新药企业价值兑现的第二曲线。这是公司首款双抗 ADC 获批临床，也是公司第三款 ADC 创新药进入临床。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","06978","LU0348735423.USD","01193","BK1566","IE00B543WZ88.USD","06160","LU0307460666.USD","02688","LU0593848301.USD","IE00BPRC5H50.USD","IE00BZ08YS42.EUR","VXUS","IE00BMCWC346.EUR","BK1521","AGIX","VTHR","LU0431992006.USD","LNGR","LU0651946864.USD","LU1051768304.USD","LU1515016050.SGD","MEDX","LU0877626530.USD","IE00BZ08YR35.GBP","159992","QTOC","BK1500","IE00BGHQDM52.EUR","ARTY","AIPO","KCAI","LU1969619763.USD","09969","BK1161","LU0640798160.USD","LU0821914370.USD","LU1808992512.USD","00135","IE0008369823.USD","IE00BZ08YT58.USD","BK4588","LU0287142896.SGD","LU1224709979.USD","KURE","IBBQ","06690","BK1574","IE00B29SXG58.USD","IE0034224299.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/KURE\",params:#limit:6,delay:false,,,undefined,":[]}}